What is the treatment for impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impetigo Treatment

For impetigo, topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment for localized infections, while oral antibiotics such as clindamycin (300mg three times daily for 7-10 days) are recommended for extensive disease. 1

Types of Impetigo

  • Nonbullous impetigo (70% of cases)

    • Caused by Staphylococcus aureus or Streptococcus pyogenes
    • Presents with honey-colored crusts on erythematous base
    • Typically affects face and extremities 1, 2
  • Bullous impetigo (30% of cases)

    • Caused exclusively by S. aureus
    • Presents with large, flaccid bullae
    • More likely to affect intertriginous areas 1, 2

Treatment Algorithm

1. Localized Infection (Limited Lesions)

  • First-line: Topical antibiotics
    • Mupirocin 2% ointment applied three times daily for 5-7 days 1, 3
      • Clinical efficacy rates of 71-93% in clinical studies 3
      • 94-100% pathogen eradication rates 3
      • Effective against both S. aureus and S. pyogenes 3
    • Alternative topicals: retapamulin or fusidic acid 1

2. Extensive Disease (Multiple Lesions or Widespread)

  • Oral antibiotics for 7-10 days:
    • First-line options:

      • Clindamycin (300mg three times daily) - excellent coverage against MRSA and streptococci 1
      • First-generation cephalosporins like cephalexin 1
      • Amoxicillin/clavulanate 1
    • For penicillin-allergic patients:

      • Clindamycin
      • Macrolides (erythromycin)
      • Doxycycline (for patients >8 years old) 1
    • For suspected/confirmed MRSA:

      • Clindamycin
      • Trimethoprim-sulfamethoxazole (160-800mg twice daily) - note: inadequate streptococcal coverage 1

Special Considerations

Pediatric Patients

  • Mupirocin has shown 78-96% clinical efficacy in pediatric populations 3
  • Avoid tetracyclines (doxycycline, minocycline) in children under 8 years due to risk of inhibiting bone growth 1
  • For hospitalized children with complicated infections, vancomycin is first choice, followed by clindamycin and linezolid 1

Treatment Duration and Response

  • Typical duration: 5-7 days for topical therapy, 7-10 days for oral therapy 1
  • Evaluate clinical response within 48-72 hours of starting therapy 1
  • If no improvement within 3-5 days:
    • Consider bacterial culture and sensitivity testing
    • Evaluate for alternative diagnosis
    • Consider need for intravenous antibiotics 1

Prevention and Hygiene Practices

  • Keep lesions covered when possible
  • Use separate towels and linens
  • Practice good hand hygiene
  • Avoid sharing personal items
  • Limit exposure to infected individuals 1

Common Pitfalls to Avoid

  1. Failure to consider MRSA in recalcitrant cases 1
  2. Using penicillin alone, which is inferior to other antibiotics for impetigo 1, 4
  3. Inadequate treatment duration 1
  4. Relying solely on topical therapy for extensive disease 1
  5. Using topical disinfectants, which are inferior to antibiotics 2, 5
  6. Not addressing underlying conditions that may predispose to recurrent infection 1
  7. Using trimethoprim-sulfamethoxazole alone when streptococcal infection is suspected (inadequate coverage) 1

Remember that impetigo typically resolves within 7-10 days with appropriate treatment, and complications such as poststreptococcal glomerulonephritis are rare (<1 case/1,000 population per year) 1.

References

Guideline

Impetigo Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Treatment of impetigo: a review.

Pediatric infectious disease, 1985

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.